US Biosimilars See A Banner Year Despite Few Approvals

Multiple Products Compete On Key Molecules As Insulins Make Transition

2020 2021 dial speed
US biosimilar competition ramped up in 2020 • Source: Shutterstock

More from Biosimilars

More from Products